Study Evaluating SC262 in Subjects With r/r B-cell Malignancies (VIVID)
Condition(s):Non Hodgkin’s Lymphoma; Large B-cell LymphomaLast Updated:March 4, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Non Hodgkin’s Lymphoma; Large B-cell LymphomaLast Updated:March 4, 2024Not yet recruiting
Condition(s):Non Hodgkin Lymphoma; Chronic Lymphocytic LeukemiaLast Updated:February 23, 2024Recruiting
Condition(s):Small Cell Lung CancerLast Updated:July 14, 2023Recruiting
Condition(s):Lupus Erythematosus; Systemic Lupus Erythematosus; SLE (Systemic Lupus); Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatous Polyangiitis; Microscopic PolyangiitisLast Updated:March 8, 2024Not yet recruiting
Condition(s):Glaucoma; Open Angle GlaucomaLast Updated:April 8, 2022Unknown status
Condition(s):Serous Ovarian Cancer; Advanced Ovarian CancerLast Updated:September 26, 2023Not yet recruiting
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 18, 2023Completed
Condition(s):Glaucoma; Open Angle GlaucomaLast Updated:November 2, 2021Completed
Condition(s):Allosensitization; Heart Transplant Failure and RejectionLast Updated:March 25, 2024Completed
Condition(s):Primary Immune ThrombocytopeniaLast Updated:November 13, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.